Radioactive [14C]5-hydroxytryptamine (5-HT, serotonin) creatinine sulphate was injected intrapleurally into female rats treated with oestrogen and/or progesterone which had received, immediately before the injection of 5-HT, homogenates of placenta, foetus, uterus or plasma, taken from pregnant rats on the 19th day of pregnancy. The placental homogenate produced a significant increase in 5-HT uptake by the myometrium, when the rats had been primed with moderate doses of oestrogen plus progesterone. Higher doses prevented the increased uptake, and oestrogen treatment alone did not induce 5-HT uptake. The highest level of 5-HT accumulation in the uterus was produced by placental extract after pretreatment with 0\m=.\5 mg. oestradiol plus 10 mg. progesterone/rat/day.
INTRODUCTION
The stimulant effect of 5-hydroxytryptamine (5-HT) on the uterus and the variable sensitivity of this organ to 5-HT are well known. During oestrus, uterine sensitivity to 5-HT is very high, and a rat uterus, after priming with oestrogen, may react with maximum responses to 5-HT dilutions as low as 10-8 or 10~9 (Abrahams & Pickford, 1956 ). Snyder, Wurtman, Axelrod & Chuw (1964) have shown that the affinity of the uterus for 5-HT is hormone-conditioned. Thus, it appears that the uterus can bind and store 5-HT, depending on the hormonal situation prevailing and this may influence uterine motility under varying physiological conditions. 5-HT administered to pregnant mice and rabbits has been shown to lead to foetal death and to produce changes in the placenta reminiscent of those seen in toxaemia of pregnancy (Poulson, Botros & Robson, 1960) .
We have reported (Sadowsky, Pfeifer, Sadowsky, Tsur & Sulman, 1963) that the urinary levels of the 5-HT metabolite 5-hydroxyindole acetic acid (5-HIAA) are raised in certain women suffering from habitual abortion not amenable to hormone therapy. Analysis of the urine of such cases showed that emotional stress with in¬ creased 5-HT production may result in increased contractility of the pregnant uterus. This observation was strengthened by unusually high peaks of 5-HIAA excretion 1 day before abortion. On the day of abortion, 5-HIAA disappeared en¬ tirely from the urine and 5-HT only was excreted. This points to a breakdown in normal 5-HT metabolism due to placental monoamine oxidase (MAO) deficiency (Sadowsky, Pfeifer, Sadowsky & Sulman, 1964 Table 1 shows the uptake of [14C]5-HT by blood plasma and uteri of steroidprimed rats which received homogenates of placentae, foetuses, uteri or plasma and of controls. Oestrogen treatment did not promote 5-HT accumulation in the uterus. Progesterone facilitated the accumulation of 5-HT in the uterus.
In columns 1 and 2, which refer to rats injected with oestrogen, 5-HT uptake/g. uterine tissue was small and not significantly (P > 0-1) different from the oil controls. None of the injected homogenates influenced 5-HT uptake by the uterus. Columns 3 and 4 show that treatment with large doses of progesterone increased 5-HT uptake by the uterus four-to six-fold, but none of the four injected homogenates produced a significantly higher uptake of 5-HT. When progesterone was given alone (column 5), the uterine uptake of 5-HT was approx. 50 % higher than that in the other rats where placental homogenate was also given. In rats which received progesterone together with a low dose of oestrogen (column 6), the highest 5-HT uptake was obtained by adding placental extract: +260% uptake (14pg./g. uterus in the sahne control rats compared with 37 pg. in the rats injected with placental homogenate).
DISCUSSION
The results show that placental extracts played an important role in the accumula¬ tion of [14C]5-HT in the uterus. This role was particularly evident when the animals were pretreated with a combination of oestrogen and progesterone. Oestrogen treatment alone did not promote the uptake of 5-HT. This was also shown by Snyder etal. (1964) .
It is well known that the 5-HT content of the uterus and of the placenta at dif¬ ferent stages of pregnancy shows considerable fluctuations as a result of a decrease in placental content of monoamine oxidase (Koren, Pfeifer & Sulman, 1965) . This has recently been confirmed by Contractor, Jones, Lee & Morris (1968) .
In mice, Robson & Senior (1964) found an accumulation of 5-HT in placental and foetal tissue and suggested that the foetus is the primary site accounting for the rise in 5-HT in the intra-uterine tissue, though they did not exclude the possibility that the placenta may also be involved. The present study indicates that it is the placenta which promotes uptake and accumulation of 5-HT in uterine tissue which may contain a protein system ('trans-serotonin') binding free 5-HT. Such a globulin system exists also for steroids (trans-cortin), iron (trans-ferrin) and vitamin B12 (trans-corrin). 'Trans-serotonin' availability would seem to depend on an optimal oestrogen-progesterone ratio in the myometrium.
Another aspect of the presence of a placental 'trans-serotonin' is its possible role in binding 5-HT in the uterus during pregnancy and releasing it at the end of preg¬ nancy due to a shift in the oestrogen-progesterone balance known to occur at term.
It has been shown by us that this may trigger uterine contractions (Koren, Pfeifer & Sulman, 1966&) .
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